{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:48:56Z","timestamp":1775915336564,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,11]]},"DOI":"10.7759\/cureus.73417","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T08:43:15Z","timestamp":1731314595000},"source":"Crossref","is-referenced-by-count":1,"title":["Relationship Between Serum \u03c9-3 Polyunsaturated Fatty Acid Concentration and Fatty Acid Fraction of Epicardial Adipose Tissue in Patients With Cardiovascular Disease"],"prefix":"10.7759","author":[{"given":"Taira","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Arikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Ohni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000132503.19410.6B","article-title":"Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies","volume":"109","author":"He K","year":"2004","unstructured":"He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation. 2004, 109:2705-11. 10.1161\/01.CIR.0000132503.19410.6B","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-09-0327","article-title":"Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortality in patients with acute myocardial infarction--data from Infarction Prognosis Study (IPS) Registry","volume":"73","author":"Lee SH","year":"2009","unstructured":"Lee SH, Shin MJ, Kim JS, et al.. Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortality in patients with acute myocardial infarction--data from Infarction Prognosis Study (IPS) Registry. Circ J. 2009, 73:2250-7. 10.1253\/circj.cj-09-0327","journal-title":"Circ J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-3-201108020-00006","article-title":"Circulating long-chain \u03c9-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study","volume":"155","author":"Mozaffarian D","year":"2011","unstructured":"Mozaffarian D, Lemaitre RN, King IB, et al.. Circulating long-chain \u03c9-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann Intern Med. 2011, 155:160-70. 10.7326\/0003-4819-155-3-201108020-00006","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi L","year":"2008","unstructured":"Tavazzi L, Maggioni AP, Marchioli R, et al.. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008, 372:1223-30. 10.1016\/s0140-6736(08)61239-8","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022, 145:e895-e1032. 10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M062034","article-title":"EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4","volume":"56","author":"Eclov JA","year":"2015","unstructured":"Eclov JA, Qian Q, Redetzke R, et al.. EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4. J Lipid Res. 2015, 56:2297-308. 10.1194\/jlr.M062034","journal-title":"J Lipid Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-5-1","article-title":"Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease","volume":"5","author":"Baker AR","year":"2006","unstructured":"Baker AR, Silva NF, Quinn DW, et al.. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006, 5:1. 10.1186\/1475-2840-5-1","journal-title":"Cardiovasc Diabetol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2017.11.004","article-title":"Serum adiponectin and TNF\u03b1 concentrations are closely associated with epicardial adipose tissue fatty acid profiles in patients undergoing cardiovascular surgery","volume":"18","author":"Sawaguchi T","year":"2018","unstructured":"Sawaguchi T, Nakajima T, Hasegawa T, et al.. Serum adiponectin and TNF\u03b1 concentrations are closely associated with epicardial adipose tissue fatty acid profiles in patients undergoing cardiovascular surgery. Int J Cardiol Heart Vasc. 2018, 18:86-95. 10.1016\/j.ijcha.2017.11.004","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2010.07.169","article-title":"Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease","volume":"165","author":"Shibasaki I","year":"2010","unstructured":"Shibasaki I, Nishikimi T, Mochizuki Y, et al.. Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease. Regul Pept. 2010, 165:210-7. 10.1016\/j.regpep.2010.07.169","journal-title":"Regul Pept"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960280303","article-title":"Aortic stenosis: is it simply a degenerative process or an active atherosclerotic process?","volume":"28","author":"Hughes BR","year":"2005","unstructured":"Hughes BR, Chahoud G, Mehta JL. Aortic stenosis: is it simply a degenerative process or an active atherosclerotic process?. Clin Cardiol. 2005, 28:111-4. 10.1002\/clc.4960280303","journal-title":"Clin Cardiol"},{"key":"ref12","article-title":"Can adults adequately convert alpha-linolenic acid ( 18: 3n-3) to eicosapentaenoic acid (20: 5n-3) and docosahexaenoic acid (22: 6n-3)?","volume":"68","author":"Gerster H","year":"1998","unstructured":"Gerster H. Can adults adequately convert alpha-linolenic acid ( 18: 3n-3) to eicosapentaenoic acid (20: 5n-3) and docosahexaenoic acid (22: 6n-3)? . Int J Vitam Nutr Res. 1998, 68:159-73.","journal-title":"Int J Vitam Nutr Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.11.018","article-title":"Dietary linoleic acid and human health: focus on cardiovascular and cardiometabolic effects","volume":"292","author":"Marangoni F","year":"2020","unstructured":"Marangoni F, Agostoni C, Borghi C, et al.. Dietary linoleic acid and human health: focus on cardiovascular and cardiometabolic effects. Atherosclerosis. 2020, 292:90-8. 10.1016\/j.atherosclerosis.2019.11.018","journal-title":"Atherosclerosis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/28.9.958","article-title":"Fatty acid composition of the plasma lipids in Greenland Eskimos","volume":"28","author":"Dyerberg J","year":"1975","unstructured":"Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr. 1975, 28:958-66. 10.1093\/ajcn\/28.9.958","journal-title":"Am J Clin Nutr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.02.084","article-title":"Omega-3 polyunsaturated fatty acids and cardiovascular diseases","volume":"54","author":"Lavie CJ","year":"2009","unstructured":"Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009, 54:585-94. 10.1016\/j.jacc.2009.02.084","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2005.04.008","article-title":"Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids","volume":"7","author":"Macchia A","year":"2005","unstructured":"Macchia A, Levantesi G, Franzosi MG, et al.. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail. 2005, 7:904-9. 10.1016\/j.ejheart.2005.04.008","journal-title":"Eur J Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2015.143","article-title":"Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?","volume":"39","author":"Iwamatsu K","year":"2016","unstructured":"Iwamatsu K, Abe S, Nishida H, et al.. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?. Hypertens Res. 2016, 39:272-5. 10.1038\/hr.2015.143","journal-title":"Hypertens Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-018-0102-9","article-title":"Eicosapantaenoic acid treatment based on the EPA\/AA ratio in patients with coronary artery disease: follow-up data from the Tochigi Ryomo EPA\/AA Trial in Coronary Artery Disease (TREAT-CAD) study","volume":"41","author":"Abe S","year":"2018","unstructured":"Abe S, Sugimura H, Watanabe S, et al.. Eicosapantaenoic acid treatment based on the EPA\/AA ratio in patients with coronary artery disease: follow-up data from the Tochigi Ryomo EPA\/AA Trial in Coronary Artery Disease (TREAT-CAD) study. Hypertens Res. 2018, 41:939-46. 10.1038\/s41440-018-0102-9","journal-title":"Hypertens Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.065520","article-title":"Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA)","volume":"150","author":"Miyauchi K","year":"2024","unstructured":"Miyauchi K, Iwata H, Nishizaki Y, et al.. Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA). Circulation. 2024, 150:425-34. 10.1161\/CIRCULATIONAHA.123.065520","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.182907","article-title":"Weight of pericardial fat on coronaropathy","volume":"29","author":"Cl\u00e9ment K","year":"2009","unstructured":"Cl\u00e9ment K, Basdevant A, Dutour A. Weight of pericardial fat on coronaropathy. Arterioscler Thromb Vasc Biol. 2009, 29:615-6. 10.1161\/ATVBAHA.108.182907","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5551\/jat.23390","article-title":"Effects of eicosapentaenoic acid treatment on epicardial and abdominal visceral adipose tissue volumes in patients with coronary artery disease","volume":"21","author":"Sato T","year":"2014","unstructured":"Sato T, Kameyama T, Ohori T, Matsuki A, Inoue H. Effects of eicosapentaenoic acid treatment on epicardial and abdominal visceral adipose tissue volumes in patients with coronary artery disease. J Atheroscler Thromb. 2014, 21:1031-43. 10.5551\/jat.23390","journal-title":"J Atheroscler Thromb"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/71.1.343s","article-title":"Dietary polyunsaturated fatty acids and inflammatory mediator production","volume":"71","author":"James MJ","year":"2000","unstructured":"James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000, 71:343S-8S. 10.1093\/ajcn\/71.1.343s","journal-title":"Am J Clin Nutr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.549527","article-title":"Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake","volume":"112","author":"Leaf A","year":"2005","unstructured":"Leaf A, Albert CM, Josephson M, et al.. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005, 112:2762-8. 10.1161\/CIRCULATIONAHA.105.549527","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(83)90181-8","article-title":"Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects","volume":"46","author":"Terano T","year":"1983","unstructured":"Terano T, Hirai A, Hamazaki T, et al.. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis. 1983, 46:321-31. 10.1016\/0021-9150(83)90181-8","journal-title":"Atherosclerosis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.07.023","article-title":"Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice","volume":"197","author":"Matsumoto M","year":"2008","unstructured":"Matsumoto M, Sata M, Fukuda D, Tanaka K, Soma M, Hirata Y, Nagai R. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis. 2008, 197:524-33. 10.1016\/j.atherosclerosis.2007.07.023","journal-title":"Atherosclerosis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)12468-3","article-title":"Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial","volume":"361","author":"Thies F","year":"2003","unstructured":"Thies F, Garry JM, Yaqoob P, et al.. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003, 361:477-85. 10.1016\/s0140-6736(03)12468-3","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh DY","year":"2010","unstructured":"Oh DY, Talukdar S, Bae EJ, et al.. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010, 142:687-98. 10.1016\/j.cell.2010.07.041","journal-title":"Cell"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2016.12.006","article-title":"Association between polyunsaturated fatty acids and inflammatory markers in patients in secondary prevention of\u00a0cardiovascular disease","volume":"37","author":"Bersch-Ferreira \u00c2C","year":"2017","unstructured":"Bersch-Ferreira \u00c2C, Sampaio GR, Gehringer MO, et al.. Association between polyunsaturated fatty acids and inflammatory markers in patients in secondary prevention of\u00a0cardiovascular disease. Nutrition. 2017, 37:30-6. 10.1016\/j.nut.2016.12.006","journal-title":"Nutrition"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2009.01.004","article-title":"alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans","volume":"80","author":"Brenna JT","year":"2009","unstructured":"Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids. 2009, 80:85-91. 10.1016\/j.plefa.2009.01.004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq501","article-title":"Dietary \u03b1-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation","volume":"32","author":"Winnik S","year":"2011","unstructured":"Winnik S, Lohmann C, Richter EK, et al.. Dietary \u03b1-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation. Eur Heart J. 2011, 32:2573-84. 10.1093\/eurheartj\/ehq501","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/314757-relationship-between-serum--3-polyunsaturated-fatty-acid-concentration-and-fatty-acid-fraction-of-epicardial-adipose-tissue-in-patients-with-cardiovascular-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T08:43:17Z","timestamp":1731314597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/314757-relationship-between-serum--3-polyunsaturated-fatty-acid-concentration-and-fatty-acid-fraction-of-epicardial-adipose-tissue-in-patients-with-cardiovascular-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.73417","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,11]]}}}